Your GLP-1 Destination

1 Walgreens Weight Management is currently available in all U.S. states except AL and LA. For Medicare Bridge patients, Walgreens Weight Management is available in all U.S. states except AL, DC, DE, KS, LA, MS, NM, RI, and WV.

Walgreens-affiliated medical practices are independently owned and operated by licensed physicians who provide services using the Walgreens virtual care program telehealth platform. For more information about the relationship between Walgreens and the medical practices click here.

Walgreens Health Medical Group California P.C. is a California professional medical corporation utilizing the fictitious name "Walgreens Health Medical Group California P.C." pursuant to Cal. Bus. & Prof. Code § 2415. To view the Fictitious Name Permit, click here.

This content references third-party trademarks that are the property of their respective owners. Such references are made for informational purposes only and are not sponsored, authorized, or endorsed by, or otherwise affiliated with, the respective trademark owners.

Please note that a GLP-1 medication may not be appropriate in all patients.

Please note that the pricing listed is not Walgreens' usual and customary price.

2 Copays as low as $25: Terms and conditions apply. Copays as low as $25 are available with a manufacturer coupon for eligible commercially insured patients on a qualifying dose. Pricing does not reflect the cash price and is subject to availability.

3 $50/month covers GLP-1 medication for weight loss through Medicare GLP-1 Bridge program only; healthcare services (including visit costs) are not included. Eligibility, prior authorization and coverage rules apply. Contact your plan or healthcare provider for details.

4 These products are not intended to treat Type 2 Diabetes or otherwise aid in weight loss. Consult your healthcare provider prior to any supplementation.

† Novo Nordisk’s Wegovy Pill Savings Offer:
For commercially insured patients with Wegovy tablet coverage: Novo Nordisk is offering Wegovy tablets for as little as $25 for 1-month, 2-month, or 3-month prescription fills to commercially insured patients with Wegovy tablet coverage. Subject to a maximum savings of $100 per month. A 1-month fill refers to 1 bottle of 30 tablets equivalents to a 30-day supply, a 2-month fill refers to 2 bottles of 30 tablets equivalent to a 60-day supply, and a 3-month fill refers to 3 bottles of 30 tablets equivalent to a 90-day supply. This offer is not valid for patients enrolled in federal or state healthcare programs (including Medicare, Medicaid, and TRICARE). Novo Nordisk reserves the right to modify or cancel this savings program without notice at any time. See full terms at WegovyTerms.com.

For patients planning to self-pay: Novo Nordisk is offering Wegovy tablets to eligible self-pay patients for $149 per month for the 1.5 mg dose, $199 per month for the 4 mg dose, and $299 per month for the 9 mg and 25 mg doses. Each one-month fill refers to 1 bottle of 30 tablets equivalent to a 30-day supply. This offer is for self-paying patients only and operates outside of any third-party insurance. Patients agree not to seek or accept reimbursement for any out-of-pocket costs from any third-party. Novo Nordisk reserves the right to modify or cancel this savings program without notice at any time. See full terms at WegovyTerms.com.

†† Novo Nordisk’s Wegovy Injection Savings Offer:
For commercially insured patients with Wegovy injection coverage: Novo Nordisk is offering Wegovy injections for as little as $25 for 1-month, 2-month, or 3-month prescription fills to commercially insured patients with Wegovy injection coverage. Subject to a maximum savings of $100 per month. A 1-month fill refers to 1 box of 4 single-dose prefilled pens equivalent to a 28-day supply, a 2-month fill refers to 2 boxes of 4 single-dose prefilled pens equivalent to a 56-day supply, and a 3-month fill refers to 3 boxes of 4 single-dose prefilled pens equivalent to a 84-day supply. This offer is not valid for patients enrolled in federal or state healthcare programs (including Medicare, Medicaid, and TRICARE). Novo Nordisk reserves the right to modify or cancel this savings without notice at any time. See full terms at WegovyTerms.com.

For patients planning to self-pay: Through December 31, 2026, Novo Nordisk is offering eligible self-pay patients new to Wegovy injections an introductory price of $199 per fill for the first two fills of medication (0.25 mg and 0.5 mg doses only). After the first two fills, the cost of Wegovy injections will be $349 per month for subsequent fills of medication. Each fill equals a 28-day supply, which is equivalent to one month of medication. This offer is for self-paying patients only and operates outside of any third-party insurance. Patients agree not to seek or accept reimbursement for any out-of-pocket costs from any third-party. Novo Nordisk reserves the right to modify or cancel this savings program without notice at any time. See full terms at WegovyTerms.com.

‡ Lilly’s Zepbound Single-Dose Pen Savings Card Program:
For commercially insured patients with Zepbound single-dose pen coverage: Through December 31, 2026, Lilly is offering Zepbound single-dose pens for as little as $25 for 1-month, 2-month, or 3-month prescription fills to commercially insured patients with Zepbound single-dose pen coverage. Subject to a maximum savings of $100 per month. A 1-month supply is defined as 28 days and up to 4 single-dose pens; 2-month supply is defined as 56 days and up to 8 single-dose pens; 3 months is defined as 84 days and up to 12 single-dose pens. Participation in the Program requires a valid patient HIPAA authorization. This offer is not valid for patients enrolled in any federal, state, or government funded healthcare program (including Medicare, Medicaid, and TRICARE). Lilly reserves the right to terminate, rescind, revoke, or amend the savings card eligibility criteria and/or term conditions at any time without notice and for any reason. See full terms at https://zepbound.lilly.com/savings/terms-and-conditions.

‡‡ Lilly’s Zepbound KwikPen Savings Card Program:
For commercially insured patients with Zepbound KwikPen coverage: Lilly is offering Zepbound KwikPens for as little as $25 for 1-month, 2-month, or 3-month prescription fills to commercially insured patients with Zepbound KwikPen coverage. Subject to a maximum savings of $100 per month. A 1-month supply is defined as 28 days and 1 KwikPen; 2-month supply is defined as 56 days and up to 2 KwikPens; 3 months is defined as 84 days and up to 3 KwikPens. Participation in the Program requires a valid patient HIPAA authorization. This offer is not valid for patients enrolled in any federal, state, or government funded healthcare program (including Medicare, Medicaid, and TRICARE). Lilly reserves the right to terminate, rescind, revoke, or amend the savings card eligibility criteria and/or term conditions at any time without notice and for any reason. See full terms at https://zepbound.lilly.com/savings/terms-and-conditions.

For patients planning to self-pay: Through December 31, 2026, Lilly is offering Zepbound KwikPens to eligible self-pay patients for $299 per month for the 2.5 mg dose, $399 per month for the 5 mg dose, and $449 per month for the 7.5 mg, 10 mg, 12.5 mg, and 15 mg doses. A 1-month supply is defined as 28 days and 1 KwikPen. New and existing patients will automatically receive the $449 offer on their first purchase of the 7.5 mg, 10 mg, 12.5 mg, and 15 mg doses. To continue to be eligible for this offer, patients must complete their refill purchase within 45 days of the delivery/received date of your previous Zepbound KwikPen prescription fill. Card may be used for a maximum of up to 11 prescription fills per calendar year. This offer is for self-paying patients only and operates outside of any third-party insurance. Patients agree not to seek or accept reimbursement for any out-of-pocket costs from any third-party. Lilly reserves the right to terminate, rescind, revoke, or amend the savings card eligibility criteria and/or term conditions at any time without notice and for any reason. See full terms at https://zepbound.lilly.com/savings/terms-and-conditions-kwikpen-self-pay.

§ Lilly’s Foundayo Savings Card Program:
For commercially insured patients with Foundayo coverage: Through December 31, 2026, Lilly is offering Foundayo for as little as $25 for 1-month, 2-month, or 3-month prescription fills to commercially insured patients with Foundayo coverage. Subject to a maximum savings of $100 per month. A 1-month supply is defined as 30 days, a 2-month supply is defined as 60 days, and a 3-month supply is defined as 90 days. Participation in the Program requires a valid patient HIPAA authorization. This offer is not valid for patients enrolled in any federal, state, or government funded healthcare program (including Medicare, Medicaid, and TRICARE). Lilly reserves the right to terminate, rescind, revoke, or amend the savings card eligibility criteria and/or term conditions at any time without notice and for any reason. See full terms at https://foundayo.lilly.com/coverage-savings#commercial-terms.

For patients planning to self-pay: Through December 31, 2026, Lilly is offering eligible self-pay patients both 0.8 mg and 2.5 mg doses of Foundayo medication for $149 per month, 5.5 mg doses for $199 per month, and 9 mg, 14.5 mg, and 17.2 mg doses for $299 per month. Each fill equals a 30-supply, which is equivalent to one month of medication. To continue to be eligible for this offer, patients must complete their refill purchase of Foundayo within 45 days of the delivery/received date of your previous Foundayo prescription fill. Card may be used for a maximum of up to 10 prescription fills per calendar year. This offer is for self-paying patients only and operates outside of any third-party insurance. Patients agree not to seek or accept reimbursement for any out-of-pocket costs from any third-party. Lilly reserves the right to terminate, rescind, revoke, or amend the savings card eligibility criteria and/or term conditions at any time without notice and for any reasons. See full terms at https://foundayo.lilly.com/coverage-savings#self-pay-terms.